Fustin ameliorates hyperglycemia in streptozotocin induced type-2 diabetes via modulating glutathione/Superoxide dismutase/Catalase expressions, suppress lipid peroxidation and regulates histopathological changes.

By post Hoc parametric test study, glibenclamide 5 mg/kg and fustin 100 mg/kg showed a favorable important (P < 0.001) drop in blood glucose after thirty days of therapy, while fustin 50 mg/kg was found to be marginally significant (P < 0.01) as opposed to a diabetic control group (P < 0.001). 3.3.

also in 26,082 other papers